Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin C-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin C

Published:2000-05 Issue:9 Volume:10 Page:865-869
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Matsumoto Naoki,Ariga Akiko,To-e Sakino,Nakamura Hikaru,Agata Naoki,Hirano Shin-ichi,Inoue Jun-ichiro,Umezawa Kazuo

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference10 articles.

1. NF-κB as a Frequent Target for Immunosuppressive and Anti-Inflammatory Molecules**This article was accepted for publication on 27 September 1996.

2. Inhibition of NF-κB Activation by Panepoxydone

3. Cycloepoxydon, 1-Hydroxy-2 hydroxymethyl-3-pent-1-enylbenzene and 1-Hydroxy-2-hydroxymethyl-3-pent-1,3-dienylbenzene, New Inhibitors of Eukaryotic Signal Transduction.

4. Epoxyquinomicins A, B, C and D, New Antibiotics from Amycolatopsis. I. Taxonomy, Fermentation, Isolation and Antimicrobial Activities.

5. Epoxyquinomicins A, B, C and D, New Antibiotics from Amycolatopsis. II. Effect on Type II Collagen-induced Arthritis in Mice.

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of MLCK‑mediated migration and invasion in human endometriosis stromal cells by NF‑κB inhibitor DHMEQ;Molecular Medicine Reports;2023-06-09

2. Synthesis and Evaluation of DHMEQ Derivatives with Tertiary Hydroxyl Group Instead of Secondary Hydroxyl Group;Chemical and Pharmaceutical Bulletin;2023-04-01

3. Isolation of the Anti-Inflammatory Agent Myceliostatin from a Methionine-Enriched Culture of Myceliophthora thermophila ATCC 42464;Journal of Natural Products;2023-02-03

4. Targeting Mast Cells in Allergic Disease: Current Therapies and Drug Repurposing;Cells;2022-09-27

5. A New 1,2-Naphthoquinone Derivative with Anti-lung Cancer Activity;Chemical and Pharmaceutical Bulletin;2022-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3